Role of dobutamine stress echocardiography for preoperative cardiac risk assessment before major vascular surgery: A diagnostic tool comes of age

Echocardiography

Volumn 17, Issue 1, 2000, Pages 79-91

  Poldermans, Don ^b   Bax, Jeroen J ^c   Thomson, Ian R ^a   Boersma, Eric ^c   Van Der Meer, Peter ^c   Fioretti, Paolo M ^c   Elhendy, Abdou ^c   Van De Ven, Louis M M ^c   Roelandt, Jos R T C ^c   Van Urk, Hero ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Dobutamine stress echocardiography; Preoperative cardiac risk stratification

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; VASCULAR SURGERY;

EID: 0033977315     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2000.tb00998.x     Document Type: Article

References (63)

1. 1. The UK small aneurysm trial participants: Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small aortic aneurysms. Lancet 1998;352:1649-1655.
2. 2. Smith T: European health challenges. BMJ 1991;303:1395-1397.
3. 3. Mangano DT: Perioperative cardiac morbidity. Anaesthesiology 1990;72:153-184.
4. 4. Sonecha TN, Nicolaides AN: The relationship between intermittent claudication and coronary artery disease-Is it more than we think? Vasc Med Rev 1991;2:137-146.
5. 5. Yeager RA, Moneta GL, Edwards JM, et al: Late survival after perioperative myocardial infarction complicating vascular surgery. J Vasc Surg 1994;20:598-606.
6. 6. Goldman L: Assessment of perioperative cardiac risk. N Engl J Med 1994;330:707-709. Editorial.
7. 7. Eagle KA, Coley CM, Newell JB, et al: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110: 859-866.
8. 8. American College of Cardiology/American Heart Association (ACC/AHA): Task force report. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. J Am Coll Cardiol 1996;27:910-948.
9. 9. Poldermans D, Arnese M, Fioretti PM, et al: Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995;26:648-653.
10. 10. Salustri A, Fioretti PM, Pozzoli MMA, et al: Dobutamine stress echocardiography: Its role in the diagnosis of coronary artery disease. Eur Heart J 1992;13:70-77.
11. 11. Poldermans D, Fioretti PM, Forster T, et al: Dobutamine stress echocardiography for the assessment of perioperative cardiac risk in patients undergoing major non cardiac vascular surgery. Circulation 1993;87:1506-1512.
12. 12. Picano E: Stress echocardiography: From pathophysiological toy to diagnostic tool. Circulation 1992;85:1604-1612.
13. 13. Bourdillon PDV, Broderick TM, Sawada SG, et al: Regional wall motion index for infarct and non-infarct regions after reperfusion in acute myocardial infarction: Comparison with global wall motion index. J Am Soc Echocardiogr 1989;2:398-407.
14. 14. Caidahl K, Kazzam E, Lodberg J, et al: New concept in echocardiography: Harmonic imaging of tissue without the use of contrast. Lancet 1998;352:1264-1270.
15. 15. Fung AY, Gallagher KP, Buda AJ: The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 1987;76:943-951.
16. 16. Poldermans D, Boersma E, Fioretti PM, et al: Cardiac chronotropic responsiveness to B-adrenoceptor stimulation is not reduced in the elderly. J Am Coll Cardiol 1995;25:995-999.
17. 17. Poldermans D, Fioretti PM, Boersma E, et al: Safety of dobutamine-atropine stress echocardiography in patients with suspected coronary artery disease. Am J Cardiol 1994;73:456-459.
18. 18. Picano E, Mathias W, Pingitori A, et al: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study. Lancet 1994;344:1190-1192.
19. 19. Poldermans D, Rambaldi R, Bax JJ, et al: Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998;19:1712-1718.
20. 20. Pellikka P, Roger VL, Oh JK, et al: Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm ≥ 4 cm in diameter. Am J Cardiol 1996; 77:413-416.
21. 21. Brown KA: Prognostic value of thallium-201 myocardial perfusion imaging: A diagnostic tool comes of age. Circulation 1991;83:363-381.
22. 22. Rochmis P, Blackburn H: Exercise tests: A survey of procedures, safety and litigation experience in approximately 170,000 tests. JAMA 1971;217:1061-1066.
23. 23. Poldermans D, Arnese M, Fioretti PM, et al: Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995;26:1197-1202.
24. 24. Davila-Roman VG, Waggoner AD, Sicard GA, et al: Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993;21:957-963.
25. 25. Eichelberger J, Schnarz K, Black E, et al: Medical value of dobutamine echocardiography before vascular surgery. Circulation 1992; 86(suppl I):I789.
26. 26. Lalka SG, Sawada SG, Dalsing MC, et al: Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992;15:831-842.
27. 27. Lane RT, Sawada SG, Segar DS, et al: Dobutamine stress echocardiography as predictor of perioperative cardiac events. Am J Cardiol 1991;68:976-977.
28. 28. Williams MJ, O'Gorman D, Shan K, et al: Dobutamine vs dipyridamole echo for risk stratification before vascular surgery. J Am Soc Echocardiogr 1995;8:406.
29. 29. Xie T, Tavackoli S, Adams M, et al: Value of dobutamine stress echocardiography in risk stratification of patients with clinical predictors of "intermediate to high risk" for peripheral vascular surgery. Circulation 1998;98I-267I.
30. 30. Langan EM, Youky JR, Franklin DP, et al: Dobutamine stress echocardiography for cardiac risk assessment before aortic surgery. J Vasc Surg 1993;18:905-913.
31. 31. Krupski WC, Layug EL, Reilly LM, et al: Comparison of cardiac morbidity rates between aortic and infrainguinal operations. J Vasc Surg 1993;18:609-617.
32. 32. Mangano DT, Browner WS, Hollenberg M, et al: Long-term cardiac prognosis following noncardiac surgery. JAMA 1992;268:233-239.
33. 33. Younis LT, Aguirre F, Byers S, et al: Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 1990;119:1287-1292.
34. 34. Lette J, Waters D, Lassone J, et al: Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 1991;14:160-169.
35. 35. Lette JL, Waters D, Cerino M, et al: Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 1992;69: 1553-1558.
36. 36. McPhail NV, Ruddy TD, Calvin JE, et al: Comparison of left ventricular function and myocardial perfusion for evaluating perioperative cardiac risk of abdominal aortic surgery. Can J Surg 1990;33:224-228.
37. 37. Coley CM, Field TS, Abraham SA, et al: Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992;69:1280-1285.
38. 38. Levinson JR, Boucher CA, Coley CM, et al: Usefulness of semiquantitative analysis of dipyridamole-thallium-201 redistribution for improving risk stratification before vascular surgery. Am J Cardiol 1990;66:406-410.
39. 39. Boucher CA, Brewster DC, Darling RC, et al: Determination of cardiac risk by dipyridamole thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-394.
40. 40. Mangano DT, London MJ, Tubau JF, et al: Dipyridamolr thallium-201 scintigraphy as a preoperative screening test: A reexamination of its predictive potential. Circulation 1991;84: 493-502.
41. 41. Baron JF, Mundler O, Bertrand M, et al: Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330:663-669.
42. 42. Hendel RC, Whitfield SS, Villegas BJ, et al: Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992; 70:1243-1249.
43. 43. Hendel RC, Hui Chen M, L'Italien GJ, et al: Sex differences in perioperative and long-tem cardiac event-free survival in vascular surgery patients. An analysis of clinical and scintigraphic variables. Circulation 1995;91:1044-1051.
44. 44. Stratmann HG, Younis LT, Wittry MD, et al: Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: Prognostic value for perioperative and late cardiac events. Am Heart J 1995;131:923-929.
45. 201Tl imaging: Assessing cardiac risks associated with vascular surgery. Circulation 1991;84(suppl III):III54-III60.
46. 46. Watters TA, Botvinick EH, Dae MW, et al: Comparison of the findings on preoperative perfusion scintigraphy and intraoperative transesophageal echocardiography: Implications regarding the identification of myocardium at ischemic risk. J Am Coll Cardiol 1991; 18:93-100.
47. 47. McPhail NV, Ruddy TD, Barber GG, et al: Cardiac risk stratification using dipyridamole myocardial perfusion imaging and ambulatory ECG monitoring prior to vascular surgery. Eur J Vasc Surg 1993;7:151-155.
48. 48. Lane SE, Lewis SM, Pippin JJ, et al: Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol 1989;64:1275-1279.
49. 49. Eagle KA, Singer DE, Brewster DC, et al: Dipyridamole-thallium scanning in patients undergoing vascular surgery. Optimizing preoperative evaluation of cardiac risk. JAMA 1987; 257:2185-2189.
50. 50. Kazmers A, Moneta GL, Cerqueira MD, et al: The role of perioperative radionuclide ventriculography in defining outcome after revascularization of the extremity. Surg Gynecol Obstet 1990;171:481-488.
51. 51. Pasternack PF, Imparato AM, Bear G, et al: The value of radionuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1984;1:320-325.
52. 52. Kazmers A, Cerqeira MD, Zierler RE: The role of preoperative radionuclide ejection fraction in direct abdominal aortic aneurysm repair. J Vasc Surg 1988;8:128-136.
53. 53. Raby KE, Goldman L, Cook EF, et al: Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol 1990;66:1309-1313.
54. 54. Raby KE, Goldman L, Creager MA, et al: Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 1989;321:1296-1300.
55. 55. Ouyang P, Gerstenbliyh G, Furman WR, et al: Frequency and significance of early postoperative silent myocardial ischemia in patients having peripheral vascular surgery. Am J Cardiol 1989;64:1113-1116.
56. 56. Mangano DT, Browner WS, Hollenberg M, et al: Association of perioperative myocardial ischemia with morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990;323:1781-1788.
57. 57. Rossi E, Citterio F, Vescio M, et al: Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography. Am J Cardiol 1998;82:306-310.
58. 58. Rose EL, Liu XJ, Henley M, et al: Prognostic value of non-invasive cardiac tests in the assessment of patients with peripheral vascular disease. Am J Cardiol 1993;71:40-44.
59. 59. Fleisher LA, Hawes AD, Rosenbaum SH: The limited predictive value of dipyridamole thallium imaging in noncardiac surgery patients. Anaesthesiology 1990;73:A75. Abstract.
60. 60. Marwick T, Underwood D: Dipyridamole thallium imaging may not be a reliable screening test for coronary artery disease in patients undergoing vascular surgery. Clin Cardiol 1990; 13:14-18.
61. 61. Vincent M, Marwick T, D'Hondt AM, et al: Prediction of perioperative events at vascular surgery: Selection of thallium scintigraphy or echocardiography with dipyridamole stress. Circulation 1992(suppl I);86:3142.
62. 62. Kataja JHK, Kaukinen S, Viinamaki OVK, et al: Esmolol for treatment of hypertension and tachycardia in patients during and after abdominal aortic surgery. J Cardiothorac Anesth 1990;4:37-43.
63. 63. Mangano D, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-1720.